ReviewMolecular cancer therapeutics2020

The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer.

Scott F Schoninger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.